Abstract:Introduction Reported sex differences in the etiology, population prevalence, progression rates, and health outcomes of people with CKD may be explained by differences in health care. Methods We evaluated sex as the variable of interest in a health care–based study of adults ( n =227,847) with at least one outpatient eGFR<60 ml/min per 1.73 m 2 measurement denoting probable CKD in Stockholm from 2009 to 2017. We calculated the odds ratios for diagnosis of CKD and provision of RASi and statins at inclusion, and hazard ratios for CKD diagnosis, visiting a nephrologist, or monitoring creatinine and albuminuria during follow-up. Results We identified 227,847 subjects, of whom 126,289 were women (55%). At inclusion, women had lower odds of having received a diagnostic code for CKD and were less likely to have received RASi and statins, despite having guideline-recommended indications. In time-to-event analyses, women were less likely to have received a CKD diagnosis (HR, 0.43; 95% CI, 0.42 to 0.45) and visited a nephrologist (HR, 0.46; 95% CI, 0.43 to 0.48) regardless of disease severity, presence of albuminuria, or criteria for referral. Women were also less likely to undergo monitoring of creatinine or albuminuria, including those with diabetes or hypertension. These differences remained after adjustment for comorbidities, albuminuria, and highest educational achievement, and among subjects with confirmed CKD at retesting. Although in absolute terms all nephrology-care indicators gradually improved over time, the observed sex gap persisted. Conclusions There were profound sex differences in the detection, recognition, monitoring, referrals, and management of CKD. The disparity was also observed in people at high risk and among those who had guideline-recommended indications. Significance Statement In this study of people with probable CKD accessing health care, we observed profound sex differences in detection, recognition, and monitoring that persisted over time: women were less likely to receive a CKD diagnosis, to visit a nephrologist, to have their creatinine and albuminuria measured, or to receive guideline-recommended therapies. Differences in comorbidity did not explain these discrepancies and were similar among high-risk groups, among patients with evidence-based indications for medications, and among patients with confirmed CKD at retesting. Efforts to improve and ensure equitable health care between the sexes could have important implications for justice and could reduce the burden of CKD. Visual

Sexually dimorphic response to tobacco in the development of chronic kidney disease: a systematic review

Cigarette smoking and second-hand smoking exposure in adolescents with chronic kidney disease: a study from the Midwest Pediatric Nephrology Consortium

Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease

Urine cotinine versus self-reported smoking and the risk of chronic kidney disease

Cigarette smoking and progression of kidney dysfunction: a longitudinal cohort study

Effects of Smoking on Renal Insufficiency and Kidney Pathological Lesions in Patients with Chronic Kidney Disease

Reprint of: Smoking and pulmonary health in women: A narrative review and behavioral health perspective

Sleeping, Smoking, and Kidney Diseases: Evidence From the NHANES 2017–2018

Sex differences in kidney metabolism may reflect sex-dependent outcomes in human diabetic kidney disease

Urinary cotinine as an objective measure of cigarette smoking in chronic kidney disease

Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate

COX-2-derived prostaglandins as mediators of the deleterious effects of nicotine in chronic kidney disease

Sex-specific differences in the epidemiology, progression, and outcomes of chronic kidney disease

Sex Differences in the Recognition, Monitoring, and Management of CKD in Health Care: An Observational Cohort Study

Sex Differences in Airway Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease

Embracing Sex-specific Differences in Engineered Kidney Models for Enhanced Biological Understanding

The Effect of Smoking on Resting Energy Expenditure in Patients with Early Diabetic Kidney Disease

Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis

In utero, childhood, and adolescence tobacco smoke exposure, physical activity, and chronic kidney disease incidence in adulthood: evidence from a large prospective cohort study

Effects of tobacco smoking on cardiovascular disease in patients with systemic lupus erythematosus: A systematic review and meta-analysis

Sex-Associated Metabolites and Incident Stroke, Incident Coronary Heart Disease, Hypertension, and Chronic Kidney Disease in the REGARDS Cohort